Dietary Modulation of Omega-3/Omega-6 Polyunsaturated Fatty Acid Ratios in Patients With Breast Cancer
Dilprit Bagga(University of California, Los Angeles), John A. Glaspy(UCLA Medical Center), Silvana Capone(University of California, Los Angeles), Hu Wang(Peking University), David Heber(Center for Human Genetics), Maria Lill(University of California, Los Angeles), Linnea Chap(University of California, Los Angeles)
Cited by 91
Related Papers
Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes
|British Journal of Cancer|2010|234
Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo
|International Journal of Oncology|2008|119
Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy
|Nature Metabolism|2024|95
Randomized, single-blind, crossover study to assess the pharmacokinetic and pharmacodynamic bioequivalence of CHS-1701 to pegfilgrastim in healthy subjects.
|Journal of Clinical Oncology|2017|8
N-acetylglucosaminyltransferase V attenuates myocardial infarction by mediating the insulin-like growth factor 1 receptor signaling pathway
|Journal of Translational Internal Medicine|2025|2